A Randomized, Double-Blind, Multi-Site, Crossover, Placebo-Controlled Equivalence Study of Morning Versus Evening Once-Daily Sustained-Release Morphine Sulfate in People with Pain from Advanced Cancer

Journal of Pain and Symptom Management

Volumn 34, Issue 1, 2007, Pages 17-23

  Currow, David C ^a   Plummer, John L ^a   Cooney, Neil J ^a   Gorman, David ^a   Glare, Paul A ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

cancer pain; chronovariability; controlled clinical trial; opioid prescribing; pain relief; Palliative care

Indexed keywords

CONTIN; MORPHINE SULFATE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; APPETITE DISORDER; ARTICLE; CANCER PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONFUSION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSAGE SCHEDULE COMPARISON; DOUBLE BLIND PROCEDURE; FEMALE; HEALTH PROGRAM; HUMAN; MALE; MULTICENTER STUDY; NAUSEA; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PAIN PARAMETERS; PALLIATIVE THERAPY; RANDOMIZED CONTROLLED TRIAL; SLEEP; SLEEP DISORDER; SOMNOLENCE; STEADY STATE; SUSTAINED DRUG RELEASE; TREATMENT OUTCOME; VISUAL ANALOG SCALE; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHINE; NEOPLASMS; PAIN; PLACEBOS; TREATMENT OUTCOME;

EID: 34250894973     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2006.10.011     Document Type: Article

References (11)

1. Glynn C.J., and Lloyd J.W. The diurnal variation in perception of pain. Proc Royal Soc Med 69 (1976) 369-372
2. Strian F., Lautenbacher S., Galfe G., and Holzl R. Diurnal variations in pain perception and thermal sensitivity. Pain 36 (1989) 125-131
3. Labrecque G., and Vanier M.-C. Biological rhythms in pain and in the effects of opioid analgesics. Pharmac Ther 68 (1995) 129-147
4. Odrcich M., Bailey J.M., Cahill C.M., and Gilron I. Chronobiological characteristics of painful diabetic neuropathy and post-herpetic neuralgia: diurnal pain variation and effects of analgesic therapy. Pain 120 (2006) 207-212
5. Citron M.L., Kalra J., Seltzer V.L., et al. Patient-controlled analgesia for cancer pain: a long-term study of inpatient and outpatient use. Canc Invest 10 (1992) 335-341
6. Gourlay G.K., Plummer J.L., and Cherry D.A. Chronopharmacokinetic variability in plasma morphine concentrations following oral doses of morphine solution. Pain 61 (1995) 375-381
7. Bell R.F., Wisloff T., Eccleston C., and Kelso E. Controlled clinical trials in cancer pain. How controlled should they be? A qualitative systematic review. Br J Cancer 94 (2006) 1559-1567
8. Gourlay G.K., Cherry D.A., Onley M.M., et al. Pharmacokinetics and pharmacodynamics of twenty four-hourly once daily sustained release morphine compared to twelve-hourly MS Contin in the treatment of severe cancer pain. Pain 69 (1997) 295-302
9. Jones B., and Kenward M.G. Design and analysis of cross-over trials (1989), Chapman and Hall, London
10. Klepstad P., Skogvoll E., Kaasa S., and Borchgrevink P.C. Circadian distribution of oral opioid consumption in cancer patients. Methods Find Exp Clin Pharmacol 22 (2000) 753-755
11. Norman G.R., Sloan J.A., and Wyrwich K.W. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41 5 (2003) 582-592